
- 积分
- 3
- 威望
- 3
- 包包
- 20
|
2,3-DPG:2,3-diphosphatidylglyceric acid,2,3-二磷酸甘油酸
3 P8 k, @! T* N S/ P2 U3 |. O2-CdA:2-chlorodeoxyadenosin,cladribine,2-氯去氧腺苷9 E+ } ?( d7 Q- F# U' Q
3H-TdR:tritiated thymide,氚标记胸腺嘧啶核苷* _5 f' U8 n5 @& o; K
5-Aza:5-azacytidine,5-氮(杂)胞苷, h5 U+ J1 T! E
a2-PI:a2-antiplasmin, a2-纤溶酶原抑制物: P; `4 ?' e V( U5 _1 l& V
AA:aplastic anemia,再生障碍性贫血
2 N( f( E/ c- r: l, W9 d9 i* bAAV:adeno-associated virus,腺病毒相关病毒
4 q e8 m6 w1 r5 N* B( ~( cAb:antibody,抗体
) m; F5 S2 S$ D: Y; g- |- aABC:avidin-biiotin complex method, 亲和素生物素复合物法
% `+ N0 R6 W: H9 {) u* }* EABMT:autologous bone marrow transplant,自体骨髓移植" q3 b/ L5 G9 R8 x
Ac:accessory cell,辅佐细胞0 I9 L6 _! `+ d/ m' g
ACD:acid citrate dextrose,酸性枸橼酸盐葡萄糖
& T0 x/ e# z' S- FACP:acid phosphatase,酸性磷酸梅3 n. V1 S* b1 J z5 ?
ACTD:actinomycin D,放线菌素D5 W* ?/ ^6 e f! E+ {
Acute:急性的 - H$ L8 q3 X" c* L, {
ACV:cyclovir,阿昔洛韦
& Z* i5 ?& x6 L4 z$ d2 j6 BAd:adenovirus,腺病毒 h% ~ y2 n/ |: Q
AD:antigen determinant,抗原决定簇
9 p. u1 G; s, S& z5 h0 hADA:adenosine deaminase,腺苷脱氨酶
T! @% u) d" L0 {ADCC:antibody-dependent cell-mediated cytotoxicity)抗体依赖细胞介导性细胞毒性( o2 z/ i! T( B8 \/ P# J6 a; y
Adjuvant therapy:辅助治疗
+ J' z. G0 [$ gAEL:acute erythrocytic leukemia,急性红白血病
, V9 N) m2 l" N8 p& O- p7 E. ~AEoL:acute eosinophilic leukemia,急性嗜酸粒细胞白血病
: s" `8 M8 o! q" _! EAFP:alpha fetoprotein,甲胎蛋白
7 \& |( H' s: t) R/ UAg:antigen,抗原
# r4 W v+ W' D! q, y7 C9 LaGVHD:acute graft versus host disease,急性移植物抗宿主病
7 Z' w3 A( c' {. K# k% g; l6 gAid:anti-idiotype antibody,抗独特型抗体* s. p0 e" |: F# o6 i! J/ X: Y
AidS:acquired immune deficiency syndrome,获得性免疫缺陷综合征" L+ t* X% a5 r8 C, ~
AIF:apoptosis-inducing factor,凋亡诱导因子# F5 v* l# Z: I5 H9 c
AIHA:autoimmune hemolytic anemia,自身免疫性溶血性贫血
% n7 A. @ g. R* ^" v5 R- B+ VAL:acute leukemia, 急性白血病
+ l$ h: X0 \2 M( Q- c- f1 HALCL:anaplastic large cell lymphoma,退行性大细胞淋巴瘤
' A. i% Y4 W# eALG:antilymphocyte globulin, 抗淋巴细胞球蛋白# m, D( Y; F5 F: `3 ~
ALIP:abnormal localization of immature precursor,未成熟前体细胞异常定位9 ?6 o+ K! T' _( @+ D2 D( t% ~0 G$ a
ALL:acute lymphocytic leukemia,急性淋巴细胞白血病5 D: }+ E1 j7 p+ v4 y0 f
Allo-BMT:allogeneic bone marrow transplantation,异基因骨髓移植7 _4 z# P/ S+ V# @9 A; q) ^% [ Q7 R
Allo-PBSCT:allogeneic peripheral blood stem cell transplantation,异基因外周血干细胞移植
t& `) W& F% u# _1 h0 b' d3 WAllogeneic:异基因的
+ f; b( a m2 \. OAllograft:异体移植物 $ z; R: p0 k0 m: U" A
Alopecia:脱发
( G* E8 `% d, U* R* z5 p/ s' GALP(AKP):Alkaline phosphatase,碱性磷酸酶# N3 B" ]8 f1 R0 e3 |! Q7 e
AM:adhesion molecule,粘附分子
) J' A. r5 x% @, lAMKL:acute megakaryoblastic leukemia,急性巨核细胞白血病( ~+ W/ T8 A7 z" x
AML:acute myeloid leukemia,急性髓性白血病
3 |8 Y- G0 M4 Y, [; o5 gAMM:agnogenic myeloid metaplasia,特发性髓外化生, _9 S" f1 z1 L
ANA:antinuclear antibody,抗核抗体 / M' n' G9 H. O& j: d0 R, o
Ana-LL:anaplastic large cell lymphoma,大细胞淋巴瘤
1 x- R0 D6 C' mAnaphylaxis:过敏症. Z6 ?4 l6 |" Y
- d' z+ G- K+ H6 |! e2 EANC:absolute neutrophil count,中性粒细胞绝对值
/ q3 V5 y3 w3 v. r( M* vAnemia:贫血! S0 G9 N& y: H0 k5 N/ k
ANLL:acute non-lymphocytic leukemia,急性非淋巴细胞性白血病7 X2 O( e* A7 p' M- b
Antibiotic:抗生素;抗生的 " k1 j4 O3 o' J
Antiemetic:止吐剂,止吐药 ) F7 z( ^# w/ R. \3 _
antineoplastic drugs:抗肿瘤药物
' T* e& h7 u0 S7 kAntisense:反义引物 B' w' K( s* Q+ W2 R) @5 h
APBSCT:autologous peripheral blood stem cell transplantation,自体外周血干细胞移植
/ @/ i" ~$ p. ^/ [$ t- |APC:antigen processing cell,抗原呈递细胞( g q) G) q# b5 N: u5 B2 M4 N) }
Apheresis:血浆分离置换法,血液成分部分清除 / m' A9 J4 t5 [) \5 C. L$ _$ P" Q
APL:acute promyelocytic leukemia,急性早幼粒细胞白血病* Z/ ~' X. u; @1 {5 P8 ^# m3 G
Aplasia:发育不良,成形不完全
+ l9 h9 U' e, m9 T0 I7 V4 E5 ^9 \Apoptosis:凋亡9 M; ^: h1 G" Z9 g) Y' G+ j9 R# B) B
Ara-C:arabinosyl cytosine,aracytidine阿糖胞苷
) g) K2 z W& ZARDS:acute respiratory distress syndrome,急性呼吸窘迫综合症;AidS-related diseases艾滋病相关疾病6 p; }( ~% j7 Z
Ascites:腹水 3 {, J! U S! F( U: q
ASCT:autologous stem cell transplantation,自体干细胞移植
1 o; B9 b' ]1 b9 ~7 pAspergillus:曲霉属
( B. r( V; y: @/ kASS:anterior superior spine,髂前上棘+ O- ]5 }1 e: @
AT1257:nitrocaphane,消瘤芥 H8 w* X$ c. y4 `2 g; ?* Z" v
ATG:antithymocyte globulin,抗胸腺细胞球蛋白) e2 s# Q! B- |
ATL:adult T cell leukemia/lymphoma,成人T细胞白血病/淋巴瘤
. c3 `. K, H0 N3 b0 x/ tATLS:acute tumor lysis syndrome,急性肿瘤溶解综合征. [ u, B5 Z" K1 W1 V
ATRA:all-transretinoic acid,全反式维甲酸
! [9 K. L, r- W/ W3 Z7 SAUL:acute undifferentiated cell leukemia,急性未分化细胞白血病& P9 d. A/ z" [% s. F5 F' u' L9 h
AuSCT: autologous stem cell transplantation,自体造血干细胞移植# j [5 s. N c) |& P8 h4 w
Autologous:自体的
2 N* b, L" M3 G$ ^. `) BAutograft:自体移植物
C0 u) t- J! |: J2 [' M3 U9 _Auto-BMT: autologous bone marrow transplantation,自体骨髓移植
: w, G3 Y6 @. l5 w- f6 zβ2-MG:β2-microglobulin,β2-微球蛋白
( ^/ I( J% Z4 |9 J4 \9 \/ a+ N8 sBack-up:备份
' }& t, r# e! B# hBCNU:Carmustine,卡氮芥,卡莫司汀8 X5 u$ B& t( Z% g; k9 U
BCR:breakpoint cluster region,断裂点丛集区
6 H% v' w: B) E' {BFU-E: burst-forming unit-erythroid,早期红系集落生成细胞8 Q% P0 ~, _8 O/ t9 K: W! k
Biopsy:活检
f2 p: M( q# q4 k' J D: E" HBlast cell:原始血细胞,母细胞 5 V1 S1 L' F8 U* h# @
Blast-CFC:blast colony forming cell,原始细胞集落形成细胞
2 |. j2 i! E6 I/ O# k3 t, oBlast crisis:原始细胞危象
; o$ K& I- I& lBm:memory B lymphocyte,记忆B淋巴细胞9 d2 _. ~7 \8 `
BMG:benign monoclonal gammopathies,良性单克隆丙球蛋白病# }7 _9 w, Q6 }
BMT:bone marrow transplantation,骨髓移植
% |3 N1 [* V, B7 lBone marrow biopsy:骨髓活检7 _* T) u# g1 |. r7 B& t
Bone marrow puncture:骨髓穿刺- T& Z' j' @% Z5 t1 j
Bone marrow smear:骨髓穿刺涂片
9 |- p2 [ v: c4 O5 eBRM:biological response modifier,生物应答调节剂
/ d7 _& { H4 o( p0 lBu:busulfan,白消安,马利兰 2 w8 |* a0 m' x% C
Buffer:缓冲,缓冲剂,缓冲液" [: r |3 {) i5 l1 g: C
CALLA:common acute lymphocytic leukemia antigen,普通急性淋巴细胞白血病抗原0 C! K) d, U& w& p* Y" ?
CAM:cell adhesion molecule,细胞粘附分子
8 I2 ~4 z+ F2 x7 `3 uCandida:念珠菌属,假丝酵母属
- z+ u8 T3 ^9 ~1 U7 aCatheter:导管 , ?: P6 z/ R2 [2 L, S
CB:cord blood,脐带血: O. p' ]) V3 f1 d7 u: d/ n) l6 O
CB1348:chlorambucil:苯丁酸氮芥
; ]) e! s6 K+ y, FCBC:complete blood count,全血细胞计数 * J& k) o; {. a' M# s( {3 j% t- w
CBCL:cutaneous B-cell lymphoma,皮肤B细胞淋巴瘤; C8 f+ d- }# E, Z( T$ l5 l
CBSCT:cord blood stem cell transplantation,脐血干细胞移植
7 v0 |4 J2 X0 w1 Q w3 L' E7 cCCI:corrected count increment,校正增值计数
2 A& k9 h% H2 J" G; ECCNSA:cell cycle non-specific agents,细胞周期非特异性药物 ' b9 T: o, O- l. `# l4 W3 } i
CCNU:lomustine,洛莫司汀,环己亚硝脲
. ^) |* ?9 X6 M9 y9 }5 \5 o' r: LCCR:continuous complete remission,持续完全缓解) ^/ q% d V2 v0 l3 q
CCSA:cell cycle specific agents,细胞周期特异性药物
* @) S! B8 y7 i6 XCD:Castleman's disease,Castleman病, f* r8 e; ^8 P8 B
CD:cluster of differentiation,分化群2 I; g5 F( ^1 y H
CD3AK:CD3 activated killer,CD3激活的杀伤细胞' T4 _5 y9 z8 R( o% L
CDK:cyclin dependent protein kinase,周期素依赖蛋白激酶
" i) {3 |8 H0 `CEA:carcinoembryonic antigen,癌胚抗原6 G; Q ?7 G c# _+ P
CEL:chronic eosinophil leukemia,慢性嗜酸性粒细胞白血病
$ L. M4 Q. E7 sCentral line:中心静脉导管,见central venous catheter. ! p6 G$ l' w! u0 k7 t
Central venous catheter: 中心静脉导管,又叫做central line,Hickman catheter
" e1 W7 P1 w2 w# a J# w0 VCentrifugation:离心
" @% s) }* [3 t8 @: ~- s/ T* CCFC:colony-forming cell,克隆形成细胞: {; f u6 a" v) O" ?( V
CFU:colony-forming unit,集落形成单位) L% | _/ H& O3 R5 ]; c
CFU-Blast:colony-forming unit-Blast,原始集落生成细胞4 t6 k" r- m, t2 j# y
CFU-E:colony-forming unit-erythroid,红系集落生成细胞6 v% T& k( v1 W; D' W( @5 u( C
CFU-G:colony-forming unit-granulocyte,粒系集落生成细胞
! T, G) N/ \4 G3 |7 t: n" iCFU-GM:colony-forming unit-granulocyte/macrophage,粒单系集落生成细胞1 h) j. X7 j+ Q
CFU-L:colony-forming unit-leukemia,白血病细胞集落生成单位
$ Q X- i: n8 f M7 r7 zCFU-MEG:colony-forming unit-megakaryocyte巨核系集落生成细胞
; i6 t5 ?8 a) ~) DCGD:chronic granulomatous disease,慢性肉芽肿病
& b1 p, y" }/ _6 `! vCGP:circulating granulocyte pool,循环粒细胞池9 w% Z/ C2 U6 ` ?# A, l4 ]
cGVHD:chronic graft versus host disease,慢性移植物抗宿主病5 N+ S# _9 n; m, I
Chemo-responsive:化疗敏感的
) ~' J+ W2 m! Y% C$ EChemotherapy:化学疗法
/ ]4 ?2 ]) W; [( BChronic慢性的
/ U" f) L0 w% n, m: v# ?C.I.:continuous infusion,持续静脉点滴
% D( q6 C; G8 yCIK:cytokine-induced killer cells 细胞因子诱导的杀伤细胞
" g- L7 s2 `4 B5 G) Q r6 l, c. F$ vCliniMACS:clinical magnetic activated cell sorting,临床级磁性活化细胞分选系统1 P, q9 u Q; X/ M, O. z$ l* P
CLL:chronic lymphocytic leukemia,慢性淋巴细胞白血病; X2 X% D7 j& o; N2 Q( I
CML:chronic myelogenous leukemia,慢性粒细胞白血病
8 _ A$ R1 g! m9 ?) q) x# B9 WCML-AP:CML-accelerated phase,慢性粒细胞白血病加速期% N7 l2 n- Z: L" z3 t9 z
CML-BP:CML-blastic phase,慢性粒细胞白血病急变期
9 Y7 ?$ O$ d! H+ NCML-CP:CML-chronic phase,慢性粒细胞白血病慢性期
7 E" w. }2 G* N2 p: l% a4 ^: V) WCMML:chronic myelo-monocytic leukemia,慢性粒-单细胞白血病% O4 z, q1 ^/ p
CMPD:chronic myeloproliferative disease,慢性骨髓增生性疾病
: p2 w4 s5 f9 W) BCMV:cytomegalovirus,巨细胞病毒
e' u) c* G a! Y+ {CNR:cytokine negative response cell,细胞因子不反应细胞" M" n$ ~- i3 |/ E6 o& A
CNS:central nervous system,中枢神经系统1 n: B6 {. T* h1 I" k, x
CNSL:central nervous system leukemia,中枢神经系统白血病- }- o0 r/ l4 v
Collection: 采集5 c( p* l9 G4 q1 c7 [2 E( k- |* m& e
Colony stimulating factor:集落刺激因子 . O$ n* U" N1 {3 F6 I
c-onc:cellular oncogene,细胞癌基因
" x% h2 ^; p# [" N' `Conditioning:预处理 1 w: o6 M1 `" K5 u) o p- O/ @" W
Conjunctivitis:结膜炎. z; G, p: @2 J r z0 k7 X( N/ U
Convalescence:恢复,恢复期5 u4 e1 n* S$ p/ [
CP:cancer procoagulant,癌性促凝物质
+ a7 m5 m) Q/ W3 j B$ K0 M7 d( uCPD:citrate phosphate dextrose,枸橼酸盐-磷酸盐-葡萄糖7 N5 n# P; `9 p3 e; ~, j6 U3 E
CPDA: citrate phosphate dextrose adenine,枸橼酸盐-磷酸盐-葡萄糖-腺嘌呤, ~( |* V) ~% M9 x6 ^% z. B
Cpmax:peak concentration,峰浓度
7 S( B7 m2 ?' gCPT:camptothecine,喜树碱
" U; X% H$ a) ? ~4 z% Q3 E3 ECR:complete remission,完全缓解# Z/ w; ^! f6 M
CRABP:cytoplasmic retinoic acid binding protein,胞浆维甲酸结合蛋白
F8 } l# G7 a, ^* ^" m2 YCRP:C reaction protein,丙反应蛋白
! \0 C2 O# G4 Y' O8 L! R* K5 qCRR:complete remission rate,完全缓解率) R3 e# Q& r% m- w9 C
Cryopreservation:冷冻保存,深低温保藏
$ c" F7 f. M0 c4 gCSF:colony stimulating factor,集落刺激因子
) ?2 f, Y! o9 W* v$ K* HCSF:cerebrospinal fluid,脑脊液! v- N7 N" q! U" h5 w
CTCL:cutaneous T cell lymphoma,皮肤T细胞淋巴瘤
0 [* h1 y. H: Z* nCTCL:central T cell lymphoma,中枢T细胞淋巴瘤
$ F U: {# I; T5 g, L! ]CTL:cytotoxicity T lymphocyte,细胞毒性T淋巴细胞 N, J8 _5 g. d: b3 D
Cyclin:周期素
6 s. }6 v2 q! A; S$ x0 cCytomegalovirus:巨细胞病毒
' `( T# f$ c4 S; IDC:dendric cell,树突细胞: `, V1 J7 c7 U3 s7 Q
D-D:D dimer,D-二聚体; u: _ r& ~. r6 c5 H* C* O
Del:deletion,缺失$ r+ t: `; k; o$ Q8 _4 @: N
Dermatitis:皮炎 , o, u: |$ K: N& g
De nova AML:非继发性急性髓性白血病
( ^0 ^0 o1 S4 U/ KDFS:disease free survival,无病生存期, u( i Z3 j8 y, K5 E! V+ `
DI:DNA index,DNA 指数$ b3 F& @6 ^# ?: [* A2 Y
DIC:disseminated intravascular coagulation,播散性血管内凝血
& `3 v8 \% l# g9 b. kDilution:稀释
! X8 f/ h+ g& j2 p- e) }DL:discordant lymphoma,混杂型淋巴瘤
4 G" K% T% j' o9 m- nDonor:供者, r# v Y n I$ I8 C
Dysplasia:发育不良,发育异常 " Y% ?" e9 d4 t( [+ [
EBV:Epstein-Barr virus,EB病毒
5 p% u& ?6 ^# Z" D9 X) B& |% r: vECM:extracellular matrix,细胞外基质8 L, K7 R0 Y+ k; H& l
-ectomy:(后缀)(外科)切除,除去,去掉 + ^1 s' }8 b, k S3 Y5 c5 o/ u1 `
Edema:水肿
' `& W6 r# B, J+ s, wEGF:epithelial growth factor,表皮生长因子
; k: J# R$ Z! L1 Q' f& I( [-emia:(后缀)血液疾病
/ r& c, s4 \9 H5 `* j7 pEncephalopathy:脑病 ) d" y1 x: `5 Q
Encode: 编码3 s' D) R n! G& z) w
Engraftment:移植物植入 5 \% o- b# t/ Y D, L
Enrich:富集- T4 u7 y! `6 m- B5 _: h& ~
Enzyme:酶 ' A% U" ]7 V, m t5 L! d8 m; k
Eosinophil:嗜酸性粒细胞
7 `6 z/ l$ V# c/ mEPO:erythropoietin,促红素,红细胞生成素 m* s" r& ~# k: g( \5 a7 b( x$ ?
ETT:essential thrombocythemia,原发性血小板增多症
6 N, @+ ]8 C+ i' sEx vivo:体外 ( W3 h; O7 s6 {, P7 H, o
FACS:fluorescence activated cell sorting,荧光活化细胞分选系统, R% `4 c' t* j; `# G9 E
FCM:flow cytometry,流式细胞分析技术
8 i4 D0 u: h# c OFDC:follicular dendritic cells,滤泡树突状细胞
# N) u1 D" H1 ]+ ?1 i, bFDGF:fibroblast derived growth factor,成纤维细胞源生长因子
# Y: Z c9 |, I" g4 N% L" XFebrile:发热的 9 H1 \& P& E/ _3 @% g6 _
FFP:fresh frozen plasma,新鲜冰冻血浆/ K1 w$ H/ z& P
FGF:fibroblast growth factor,成纤维细胞生长因子
+ Y Z/ b# d; `$ E: B/ ^; IFHH:familial hemophagocytic histiocytosis,家族性嗜血组织细胞增生症
7 ^- z0 [1 G4 HFISH:fluorescence in situ hybridization,荧光原位杂交
- c; N0 M7 B# W+ f# DFMF:familial Mediteranean fever,家族性地中海热
5 H7 z& n3 B7 I) w- NFoley catheter:弗利氏导尿管,气囊导尿管
1 ^7 S0 h* }* ?3 W4 b; P& S# QFrTBI:fractional total body irradiation,分次全身照射
6 u! a8 m. X0 e) Y) AFSRC: 胎羊体内增殖的人造血干细胞7 G! m' ?: Q ^" x
Fungus:真菌 6 m% @3 p! w( L! f: a) I
Fungi: Fungus复数形式( k& ~5 J- h7 i8 k [
G6PD:glucise-6-phosphate dehydrogenase,6-磷酸葡萄糖脱氢酶
4 y6 L6 t- j% o9 ~Gastritis:胃炎 * p+ F+ \1 `( r, v9 Y; ?/ H
Gastrointestinal:胃肠道的 9 T5 @% J3 y+ \% h6 i
G-CFC:granulocyte colony forming cells,粒细胞集落形成细胞
2 B4 v/ _% A9 Q# M9 J9 R$ xG-CSF:granulocyte colony stimulating factor,粒细胞集落刺激因子
, T' _3 z3 D( H0 x- L/ mGCV:cytomegalovirus,巨细胞病毒/ {, M4 m5 ^# M
GCV:ganciclovir,更昔洛韦
) {4 a/ m3 q, ]% w5 m* I/ UGI:gastrointestinal,胃肠道的
" X# I; N$ _6 `% vGM-CSF:granulocyte-macrophage colony stimulating factor,粒-巨噬细胞集落刺激因子 ) F8 q5 ^0 j, J) r& g- P
GM-CFC:granulocyte-macrophage colony forming cells,粒-巨噬细胞集落形成细胞* f3 a$ Q% y& {
Graft rejection:移植排斥(反应) ; Z$ j9 i8 r1 }1 v9 M e# D$ z1 [
Graft-versus-host disease:移植物抗宿主病
, ]" B- Z# G- r0 Z* s) K+ eGranulocyte:粒细胞 & d |# f) }# s) [( q! ~
Growth factor:生长因子
2 C @, `; A6 y. V6 ?GTR:granulocyte turnover rate,粒细胞转换率% X9 U2 ?$ n% I+ h0 l" w+ x- N
GVHD:graft-versus-host disease,移植物抗宿主病 , C3 g. U& @+ c* S9 w
GVHR: graft-versus-host reaction,移植物抗宿主反应8 ?- G! R% @, V- y% |: Y6 ~
GVL:graft-versus-leukemia,移植物抗白血病) m* Y0 {4 _4 b$ s
GVT:graft-versus-tumor,移植物抗肿瘤
, ~& o* ]5 E" e. U- WHaploidentical: 半相和的( D: L' B, {$ y0 X+ w
Harvest: 收集,采集
) {/ H9 ^2 [) Y7 I& j# xHC:hemorrhagic cystitis,出血性膀胱炎
1 Q- i$ b e* f+ oHCL:hairy cell leukemia,毛细胞白血病
: d/ ~% Q9 E8 J& w- |HD:Hodgkin's disease,霍奇金病
$ |3 l0 O1 O) B4 @$ y% [$ F/ W* ZHD:high dose,大剂量
5 t. T! j* r. E# u/ ?$ \( mHematocrit:红细胞压积
; a& j4 H& h8 H9 m9 FHematology:血液学 2 Q: p' [) }- [( B* Q0 Y' q
Hematopoiesis:造血作用,生血作用
7 y8 x& m, p, [, M [Hematopoietic system:造血系统
# ]6 q: ]# B& g9 r( uHemoglobin:血色素,血红蛋白
1 |4 F4 Q+ T( X' ^7 z6 kHemorrhage:出血 ; v5 j/ {. J$ s& V3 n
Hemorrhagic cystitis:出血性膀胱炎 9 h5 a( f. B8 \2 L$ |0 n
Hepat - :(前缀)肝的, r" E5 ~/ P- N4 ~
Hepatitis:肝炎 $ F. a, G1 T, y$ U1 V! } @4 M
HES:hypereosinophilic syndrome,高嗜酸粒细胞综合征$ j% C i2 J5 o9 R% v
HGF:hematopoietic growth factor,造血生长因子# c# G) \* J# U2 G; V
HHV:human herpus virus,人疱疹病毒+ L {0 z5 F5 B, j9 G6 ?! p
Hickman catheter:Hichman导管,中心静脉插管 ; `3 ]6 `3 m, a1 b2 ]2 v
HIV:human immune deficiency virus,人免疫缺陷病毒
8 s0 ^ M& m( t. v }' c( p5 lHLA:human leukocyte antigen,人类白细胞抗原 # P. J" _5 }$ F6 O' ^: j: }5 K% S8 n
HLH:hemophagocytic lymphohistiocytosis,嗜血细胞性淋巴组织细胞增生症* \' ~5 L3 j; W
HMR:histiocytic medullary reticulosis,组织细胞性髓性网状细胞增生症( y n4 i, `1 \: N# s
Homogenic transplantation:同基因移植! R3 A% ]* u% W( c
Homozygote:纯合子# y. }8 p' H! K4 y5 t
HPC:hematopoietic progenitor cell,造血祖细胞) P! R! i- N) j1 m2 i
HPP-CFU:high proliferative potential colony-forming unit,高增殖潜能集落形成单位( D0 y0 O, ]* y8 {. g
HR-ALL:high risk ALL,高危型急性淋巴细胞白血病% E; G1 B: ~3 Y- K2 A7 C& e3 |' W
HSC:Hand-Schuller-Christian disease,韩-薛-柯病
: N4 S3 J) k& b5 c& `8 f7 bHSC:hematopoietic stem cell,造血干细胞
8 B/ \0 \: c1 Z( B0 e5 M2 p$ y& ?' |HSR:homogenously staining region,均染色区
" ^; a" p1 G- U4 g3 F* x8 b1 m, jHSV:herpes simplex virus,单纯疱疹病毒
# W" I/ c/ ~- u& E' OHTC: typing cell,纯合子分型细胞
; z& J8 B U4 W3 D; uHTLV:human T cell leukemia virus,人类T细胞白血病病毒
, z" O) o I* Q( e, CHVOD:hepatic venous occlusive disease,肝静脉闭塞病6 U* ^9 A2 y4 U8 s# a! y7 [: Z" { W
Hyper- :(前缀)高,超,(过)多8 L u; c% b, l, U% w
Hyperalimentation:高营养支持,静脉高营养+ n" I) {* \4 S( i; e
Hyperpigmentation:色素沉着过度
& {) y6 \+ E5 T) G# A8 O: g9 P/ OHypertension:高血压 2 W! o& m6 A4 }# E1 |
Hypo- :(前缀)(过)低,少于& e# L- W, w4 V/ G
Hypotension:低血压
0 r; x+ T7 a; S% n: v5 |+ _$ oIAHS: infectous-associated hemophagocytic syndrome,感染相关嗜血细胞综合征
7 [: C7 x( ^( b7 H; K$ C6 vid:medium dose,中剂量5 g* c5 R8 E6 Y @ A$ a7 v8 P
id:initial dose,初始剂量) x! F) }4 k0 I1 i
IF:involved field,累及野
9 n0 Z) c6 S! y7 w( O( }# [IFN:interferon,干扰素9 b& y' M6 M) n: g
Ig:immunoglobulin,免疫球蛋白
, |7 J: ^1 p1 T1 |8 h) ~2 ^IGFs: insulin-like growth factor,胰岛素样生长因子
* t/ T! a( x5 M2 D+ `- Q1 mIgH:immunoglobulin heavy chain,免疫球蛋白重链! X l) e' D+ l7 s% N( Q8 `' }
IL:interleukin,白细胞介素
0 d5 o5 l' }* KIliac crest:髂嵴
+ ~1 j* O# u$ TI.M.:intramuscular,肌肉注射
4 ^2 c% o' s7 ZImmune system:免疫系统 4 Z* r; x9 u: Q3 i- h
Immunocompromised:免疫受损的 ! U; y/ v% C, |. j, B. j# W. `
Immunoglobulin:免疫球蛋白 0 f1 @! d0 F! Z9 F3 S
Immunological tolerance:免疫耐受
% G! p/ D7 N* ~8 ^- a4 }" \6 J6 kImmunosuppression:免疫抑制
% i& n+ U# @# I6 q" a: W/ jIncubation:孵育
[0 W I0 H) `informed-consent:知情同意3 ^6 f2 E1 D/ m
Intravenous:静脉内的
; C: A+ f7 ^( T( pinv: inversion,倒位. A) H" e5 f: C& Z. W
in vitro: 体外,离体
: C* c$ w. P( e& K5 o7 pin vivo: 体内
Z( D8 |6 V& H: B8 f m$ `IP:interstitial pneumonia,间质性肺炎3 |1 M! f- ^* O' G0 W$ q7 E6 y
Isolation: 分离
* a! m* O0 j0 O' O/ h# K2 e tI.T.:intrathecal injection,鞘内注射! @. W3 s! P6 a! W8 i& |
-itis:(后缀)炎症
& e, ^8 J8 W/ B2 |ITP:idiopathic thrombocytopenia purpura,特发性血小板减少性紫癜
; Z/ a0 e/ T" |* g+ }; TJaundice:黄疸
* n) M4 N7 \5 Z* N! ]: gKPS:Karnofsky score, Karnofsky评分. X1 I+ w- V+ ]
LAK:lymphokine-activated killer(cells),淋巴因子激活杀伤(细胞)
1 b" p) V. L: m8 [* FLaminar air flow unit:层流间
* e( h- O! t5 h, S+ q9 {: pLCH:Langerhans cell histiocytosis,郎格罕细胞(组织细胞)增生症
- N2 l0 T8 f7 }, N5 j4 nLD:lymphocyte depletion,淋巴细胞消减型
% e2 L; F' e7 YLD:low dose,小剂量
) h* E! b+ _& Y0 g5 z0 aLDH:lactate dehydrogenase,乳酸脱氢酶! z3 A. ]5 ?3 [1 i. t
Leukapheresis: 白细胞采集物
, \( p5 j T) J( s& n! y' H. LLeukemia:白血病
& y! H L6 R2 y* yLeukocyte:白细胞 q/ G4 x7 g; p) m& W9 L% m
Leukopenia: 白细胞减少症
: J, W: g. {9 tLFA:lymphocyte function associated antigen,淋巴细胞功能相关抗原 ' c- U) Z( s/ l: s
LFS:leukemia free survival,无白血病存活期- p7 c! _$ L# y& o& n
LGL:low grade lymphoma,低度恶性淋巴瘤" V, w! n7 {) m s( U" P0 q Y& k( w' {
LHR:lymphocytic homing function receptor, 淋巴细胞归家功能受体
$ K/ q4 @: @, A. B( o$ zLI:labeling index,标记指数! O4 Z' {& r. [( n2 f& [! c+ G
LIF:leukemia inhibition factor,白血病抑制因子) e b8 `3 X& R. ~; q0 P0 h; V' J4 h
Lineage:系
) {. e% P+ {' `8 Q; nLOH:loss of heterozygosity,杂合性丢失# P. o1 a6 d! H2 F
LP:lymphocyte predominance,淋巴细胞为主型' e. b2 s# O8 K+ O6 R' I: m/ d
LRP:lung resistance related protein,肺抗性相关蛋白
2 {) m: m3 ]9 I1 u, x ^9 WLTB:life-threatening bleeding,致命性出血
- T: G2 B8 O4 V$ BLTC-IC:long-term culture-initiating cell,长期培养起始细胞/ S+ [ ~4 M! h. O
LTR:long terminal repeat:长末端重复序列: C8 f0 Q% E0 s0 w8 w Y0 V
LVL:large volume leukapheresis,大容量白细胞单采4 k/ O# n3 D, Z8 w' m
Lymphocyte: 淋巴细胞5 \0 X0 _& S' J3 \7 S
Macrophage:巨噬细胞
' g# _0 l$ A: F. Y% W3 @MACS:magnetic activated cell sorting,磁性活化细胞分选
* l3 N: K! Q" ?; [) v% hMAK: monocytokine-activated killer(cells),单核细胞因子激活杀伤(细胞)
( g3 J& |& [- v# s, xMalabsorption:吸收障碍
# L& q& n! `" C" ^0 HMALT:mucosa-associated lymphoid tissue,粘膜相关淋巴样组织÷, Y3 e5 Z7 A/ U O0 _, U
Matching:配型8 |. N! x5 z$ S* {/ x4 r$ ]* ?
MBDI:marrow blast decline index骨髓原始细胞减少指数
3 V0 S: ~% Z0 t V1 g! ^* |' fMC:mixed cellularity,混合细胞型
- ^/ q4 y2 @! a/ L4 j. @0 D% UMcAb:monoclonal antibody,单克隆抗体
: x$ S7 E4 Z' t+ b) P- H2 N4 rmCR: median complete remission,中位完全缓解 6 j3 @0 {, t7 x
MDR:multiple drug resistance,多药耐药
& o( }5 ^( A6 v2 p/ pMDS:myelodysplastic syndrome,骨髓增生异常综合征
% L) s& C! W) O0 S5 YMegakaryocyte:巨核细胞
9 f% `4 {. v9 Z" ]- LMetabolite:代谢物 # ~/ ` I5 T \8 [5 e: P% h+ [
Metastatic:转移的 % Q8 I" V; u# }4 t; u& M! E2 I$ j W) E& a
MF:myelofibrosis,骨髓纤维化% J; m; e2 L9 D% C# X+ v, J: O% q4 f
MF:mycosis fungoides,蕈样霉菌病9 W. Z; R9 r. m- C' k% }, V+ b
MGDS:megakaryocyte growth and differentiation factor,巨核细胞增殖分化因子
+ q( q3 B, D2 T8 ]2 j: yMGP:marginal granulocyte pool,边缘粒细胞池) T4 @9 w' Y" V' G' t# U1 N3 T
MGUS: monoclonal gammopathy of undetermined significance,未定性的单克隆γ球蛋白血症7 C9 a" b) B% J! ?- \( e% {* B* ~
MH:malignant histocytosis,恶性组织细胞增生症4 d7 }3 m. s# k# F/ v
MHAS:minor histocompatibility antigen systems,次要组织相容性抗原系统
% @* F. O+ G* ~6 x7 IMHC:major histocompatibility complex,主要组织相容性抗原复合体
1 ~4 r: O3 ~' G( l) q/ Y; |6 G& MMLC:mixed lymphocyte culture,混合淋巴细胞培养
* z7 t& Q! b. D1 @MLL:mixed lineage leukemia,混合系白血病
' G0 `5 l" b" K8 H0 ?# \% N1 nMM:multiple myeloma,多发性骨髓瘤3 b$ n8 L: h3 M# q8 t t
MNC:mononuclear cells,单个核细胞4 I& Y ~" Y* ^) A3 M: L, [$ g
Mobilization:动员5 G: v; f3 A. [1 w+ z# v5 Y
Monoclonal antibody:单克隆抗体
: \3 Z/ F0 b( cMonocyte:单核细胞
+ Z& v8 H1 e8 u0 v, B$ l. r; TMonozygotic:单合子的3 E0 ]0 B" G' ~# N: V! z( M, ]
Morbidity:发病率 6 d3 E, r! \ h" n' J0 |
MPD:myeloproliferative disease, 骨髓增殖性疾病
* _2 z% b% m# N' f- h- j% Q- IMPO:myeloperoxidase,髓过氧化物酶
/ W. @3 N$ m: e# {" w( o3 D2 qMRD:minimal residual disease,微小残留病变
% ]" N) _. c% \, z7 ` L: Y' wMRP:multidrug resistance-associated protein,多药耐药相关蛋白. m9 ~5 l6 X. C8 L2 ?& U: j
Mucositis:粘膜炎
" v, K' `2 i/ x* R; l, q9 ]4 b, o" pMUD:matched unrelated donor,非血缘关系配型相合供体; A$ g2 y" {: r+ v4 Y
NAP:neutrophil alkaline phosphatase,中性粒细胞碱性磷酸酶
5 w& x- F1 R9 ONB:neuroblastoma,神经母细胞瘤
( |% X$ a; z& W- a% x# g4 fNBM:normal bone marrow,正常骨髓) a2 `+ m# ~5 b: ^- ]# f: |+ r
Negative selection:阴性选择
7 b U9 K; {& T3 y: o( i dNeuro- :(前缀)神经的
7 {! i7 e0 b* [& @3 k6 G3 jNeutropenia:中性粒细胞减少症
. ^( X2 ~) r9 T- }5 @( S+ rNeutrophil:中性粒细胞
1 _; s! d' t- ^2 p9 C2 BNG:neutrophil granulocyte,中性粒细胞6 P1 L5 F3 h; @/ S x
NGF:nerve growth factor, 神经生长因子* ~" m* j8 v) U4 |: t6 l
NHL:non-Hodgkin's lymphoma,非霍奇金淋巴瘤' x! @# r/ A2 v/ @/ U3 d2 N
NK: nature killer cell,自然杀伤细胞
4 w1 W8 R5 n% G: GNonmyeloablative transplantation: 非清髓性移植
: k. Y8 _ V8 I/ u6 iNPO:不能进食 ' T: R$ C! v( {
NS:nodular sclerosis,结节硬化型
3 Z" H5 E$ M# n" q& t9 SOncology:肿瘤学
6 c8 F; p0 I2 {6 \Oto- :(前缀)耳的7 g4 A/ o1 R+ x
PA:plasminogen activator,纤溶酶原激活物
# ^3 q1 O2 v! ?! J( pPacked red blood cells: 压积红细胞
* u( |; b% s# ?6 n9 C: H/ ?# E) t8 oPAE:post antibiotic effects,抗生素后续作用
& ?0 N* A: O+ jPAI:plasminogen activator inhibitor,纤溶酶原激活物抑制剂5 ~3 y( Y& h5 s9 p
Palliative:减轻的,缓解的 # ~! w7 W6 F, M: P' e1 m
palliative care unit (PCU):终末期病房,临终关怀病房
$ ~: @5 q( x: J: c" b3 }4 ?Pancytopenia:全血细胞减少症
+ m. R$ D6 g$ z. C4 m-pathy:(后缀)病 4 b3 q1 H- v# A6 [ b
PB:peripheral blood, 外周血
% k+ Z3 G+ r0 k- j" KPBL:peripheral blood lymphocyte,外周血淋巴细胞
2 Z% M' F" z7 w( P2 ]* FPBPC:peripheral blood progenitor cell,外周血祖细胞
* \6 ^4 t* Q! Z' K% dPBSCT:peripheral blood stem cell transplantation,外周血干细胞移植
4 g; H/ l+ `5 |8 ?. R7 e& j) @( qPCA:procoagulant activity,促凝活性物质2 u* v$ \/ ?- |8 v& S
PCD:programmed cell death,细胞程序化死亡
9 F/ o# _$ W$ L) r3 _PCL:plasma cell leukemia,浆细胞白血病
; m n# [9 L: Q g _7 |PCLI:plasma cell label index,浆细胞标记指数5 T' M+ n5 d# \$ \+ @
PCR:polymerase chain reaction, 多聚酶链反应
2 \: a1 Q7 e* `PCR-RFLP: PCR-restriction fragment length polymorphisms,限制性片段长度多态性分析
- g! e4 \/ ^. ]; @2 D& XPCR-SSOPH: PCR-sequence specific oligonucleotideprobe hybridization,序列特异性寡核苷酸探针杂交5 A% l- l' L% [
PDD:percentage depth dosage,百分深度剂量# v7 y& T4 D1 p
PDGF:platelet derived growth factor,血小板衍生生长因子
) ?& U# F+ _3 I1 E' E$ gPDR:primary drug resistance,原药耐药
% C' |( A( R4 [6 ~1 g3 L' rPE:plasma exchange,血浆置换6 M5 e. b6 k6 H1 R" n
-penia:(后缀)缺乏,不足
! S4 F% |! O* f! f: kPeripheral neuropathy:周围神经病变
: |' @3 q8 M3 O) I% i6 }: v, APetechiae:瘀点,瘀斑 , @. d2 Q2 G( N% q: H
Pfu: plaque forming unit,空斑形成单位
3 B$ N1 P; n/ \PHA:phytahematoagglutinin,植物血凝素4 _5 Q: `" u6 X+ {9 o
Phlebitis:静脉炎
1 A7 [. m! |& q& @3 l CPHSC:pluripotential hematopoietic stem cell,多能造血干细胞
: u4 E% i0 d% ]9 M: T- d-plasia:(后缀)发展,形成 . S7 }0 u [7 @9 o$ _6 f
Plasma:血浆
" l/ K8 U x2 e" X" H3 XPlasma cell: 浆细胞 : @9 O4 D4 u* T6 g/ J
Platelet:血小板
/ Y4 T4 J4 B9 Q7 L6 E* D2 GPLG:plasminogen,纤溶酶原
% n+ r* h6 Q2 y$ ]6 C" MPLL:prolymphocytic leukemia,幼淋巴细胞白血病6 |. T" Q6 q) B* d' O& @+ h: Y
PLT:platelet,血小板
1 b* }# V1 T' h+ wPLT:primed lymphocyte test,预致敏淋巴细胞试验
- G& I4 ^3 n3 A* xPMN:polymorphonuclear leukocyte,多形核白细胞* K. S6 {0 b2 i3 T
PNH:paroxysmal nocturnal hemoglobinuria,阵发性睡眠性血红蛋白尿÷
: A A) s3 \1 u' U& H9 j3 wPNRE:p53 negative response element,p53阴性反应元件
; W6 b* p: f/ D APOD:PML oncogenic domain,PML癌基因结构域
9 d% p0 t* { q0 M1 f" gPolycythemia:红细胞增多症
6 p& |1 ]9 B4 [9 }Positive selection:阳性选择
* ^9 F- ]! p7 k2 v( f1 @PPSC: pluripotent hemotopoietic stem cell,全能造血干细胞: B5 c3 M+ Y2 N5 U3 y t
Preparative regimen:预处理方案
# i5 ]3 ]# n# w0 N% t$ mProgenitor:前体,祖先
" n2 s" @( ~& m+ h8 w# GPrognosis:预后 % I% M2 Q8 r$ A" h" }& C
Prophylactic:adj.预防的;n. 预防性,预防药1 v+ m- a, K9 `8 P) ~
Prophylaxis:预防法,预防
, o# J$ R6 _2 J/ S9 B- _* [; HProtocol:草案,协议,治疗方案
& t, R, w- ^' O2 |! ]Proto-onc: proto-oncogene,原癌基因& F4 |7 \! h3 z& ^& P
PSS:posterior superior spine,髂后上棘" V) r/ a! q+ I N( x Y
PT:prothrombin time,凝血酶原时间
& J: q2 [/ Z d3 B4 q# oPTCL:peripheral T celll lymphoma,外周T细胞型淋巴瘤
( I' b" E. G5 {- o0 V5 j. E) VPTH:post-transfusion hepatitis, 输血后肝炎
- D! u. R) |1 d0 ~5 [) g! mPulmonary:肺的 1 n! Z! a6 i' |/ r% @: O( D1 n+ t# `$ _
Purging:净化- y+ A! |; s3 D N" \, n
Purity:纯度
8 ]* r8 M$ n, g! d0 xPV:polycythemia vera,真性红细胞增多症
; s- L. Z2 C& c* C8 L; GQuality of Life (QOL):生活质量7 G7 b" T% ]5 }' S& a
RA:refractory anemia,难治性贫血
d, @1 e' X- b; O5 p( Y) ~& }% s: gRAEB:refractory anemia with excessive blasts,难治性贫血伴原始细胞增多型
# C |+ a6 L8 Q% lRAEB-T:refractory anemia with excessive blasts,transformation,难治性贫血伴原始细胞增多转化型9 `0 W' j; J2 |+ [7 O
RAR:retinoic acid receptor,维甲酸受体
: E8 d. g" n% aRAS:refractory anemia with sideroblasts,难治性贫血伴环状铁粒幼细胞增多: u+ [. f4 j1 ]* U1 p
RAS:retinoic acid syndrome,维甲酸综合征
( X9 v2 F2 B0 g) h4 P* _RB:retinoblastoma,视网膜母细胞瘤) I3 P) l. ]# s I6 W2 A
RBC: red blood cell,红细胞 # F3 l( ^$ M' V n6 {1 U
Reagent:试剂
) z! q( y; R8 M9 L/ k0 A; s7 ~Recipient:受者
2 K- l& ~$ ]- q+ U/ ^8 W# RRejection:排斥* ?' a' X% R' d D! r
Relapse:复发
) d' T2 W& a2 C# i1 s& G# `Remission:缓解 : n% s* m* w; g) f5 a! r, A
Renal:肾脏的,肾的 1 r; s- w% d' l
RFS:replase free survival,无复发生存, s, r* \4 p- L, f+ b+ E% K
RPC:radiation protective competence, 辐射保护能力
- c; ~1 Y( z' DRegimen-related toxicity (RRT):预处理相关毒性
# F% B$ @6 J* @+ ]) x# d' x0 ]RT-PCR:reverse transcription polymerase chain reaction, 逆转录多聚酶链反应' ^% w0 M4 w4 Y+ }2 w# o0 j
SBB:sudan black B,苏丹黑B5 U8 f$ @, D- J% B5 Q
SCE:sister chromatial exchange,姐妹染色单体交换- ~9 ~+ n% w3 V3 T+ Z# `8 D
SCF:stem cell factor,干细胞因子- D. G$ O% j( n: l
SCid:severe combined immunodeficiency disease,重症联合免疫缺陷
C, i4 e8 M0 G. v3 ESCL:stem cell leukemia,干细胞白血病
. W- s; U9 {6 g9 i. J3 }SE:specific estarase,特异性酯酶
2 s3 j2 H# {/ V2 G/ n# |Selectin:选择素
! {, n' ?& M! F* l/ {$ n1 tSense primer:同义引物) y( N& J1 D- ]5 C/ v% w
Separation:(细胞)分选9 d+ E6 b8 [9 V' z2 [
Sepsis:脓血病,败血病 5 y5 m4 {5 S3 P2 u& V, O
Sequencing测序8 {, }' l1 t; A, \& \
SF:serum ferritin,血清铁蛋白, J. \$ s ]# k5 ?$ F
SHML:sinus histocytosis with massive lymphadenopathy,窦性组织细胞增生症伴块状淋巴结肿大4 n- t6 A# Z/ l# v3 o4 o p5 F
SIA:stroma-support immunocytometric assay,基质支持免疫细胞流式细胞仪技术法
+ O3 P+ k5 D: L: z& P+ c3 n. t: {SLE:systemic lupus erythematosus,系统性红斑狼疮
/ D$ F: T6 m( `, J; E6 k4 WSLL:small lymphocytic lymphoma,小淋巴细胞淋巴瘤
* F! p3 o# q$ tSolid tumor:实体瘤* q" f0 V2 x9 {, ^/ r2 J7 B2 d$ d# ?
SR-ALL:standard risk acute lymphocytic leukemia,标危型急性淋巴细胞白血病
8 ?7 c% x' x- X3 J( ~SRC:SCid/NOD小鼠体内增殖的人造血干细胞,SCid造血重建细胞/ M. Y7 x, f3 p
SS:Sezary syndrome,Sezary综合征
0 M: c. X% L2 a& f, RStem cell:干细胞: ^& [! r5 O% x* I N9 R
STNI:subtotal nodal irradiation,次全淋巴结照射 " k! r% c6 m* ^+ K, R
Stomatitis:口炎 ' U+ ~1 I: J% M- [5 Z/ U# v
Subclavian catheter:锁骨下导管
/ I: q# I! l7 q9 W" N, p5 p2 s$ jSupernatant:上清
5 N; B* M1 D1 f8 @, e3 u: QSyn-BMT:Syngeneic bone marrow transplant:同基因骨髓移植 ! g! _6 f* m1 M( Y, W3 E, N0 D- O
Syngeneic:同基因的
( T3 [- R9 M+ e- e! q8 |8 F6 R& FTAM:tumor associated macrophage,肿瘤相关巨噬细胞
& O, P$ D g/ O- j7 ct-AML:treatment associated AML,治疗相关的急性髓性白血病
9 z6 u1 n) [* n2 ^! g3 OTA-GVHD:transfusion associated graft-versus-host disease,输血相关的移植物抗宿主病
+ A% E* `5 s. W0 A: o2 [3 fTAA:tumor associated antigen,肿瘤相关抗原9 B( J( c1 b7 G( ]' ]/ n: r0 E
TBGP:total blood granulocyte pool,总血液粒细胞池" V9 e3 |" n( g
TBI:total body irradiation,全身照射
; ` d' S/ C% T. H9 Z( v1 nTc:time of cell cycle, 细胞周期时间( o; I8 X( W+ ^
TCD:T cell depletion, T细胞去除: q7 @$ N& a' z6 ?4 \3 w1 [
TCL:T cell leukemia/lymphoma,T细胞白血病/淋巴瘤 % o, A4 h* J' C9 l$ `2 Z
TCR:T cell receptor,T细胞受体
5 `4 P9 ?8 {" Q- A8 J: x# _5 jTCS:tumor cell survival,肿瘤细胞成活
& B4 J: A/ Q) n3 ]TEN:total enteral nutrition,完全胃肠内营养
# r* H; j% H5 P9 c3 B! Y d9 F1 V$ ATF:tissue factor,组织因子3 ]0 w1 H6 C# Q' @8 o: b
TF:thymic factor,胸腺因子
- w7 Z+ q' J- t5 m4 TTFPI:tissue factor pathway inhibitor,组织因子途径抑制物
8 m% q: }% U+ u; e0 Y" [, @TGF:therapeutic gain factor,治疗获得系数
9 t& t1 s; @0 H$ g5 n+ a' @8 k" jTGF-β:transforming growth factor-β,转化生长因子β
3 l6 f w, Z ~$ z; r8 {Thrombocyte:血小板 9 I2 I2 p/ R2 O! @2 \0 y7 e
Thrombocytopenia:血小板减少症
7 ~% j2 X' {6 a9 yTIL:tumor infiltrate lymphocyte,肿瘤浸润淋巴细胞
* U$ y% i4 `% z1 qTL:testis leukemia睾丸白血病9 }# Y$ H9 e! f0 w
TLI:total Lymphoid irradiation,全淋巴照射
. r+ T( O+ z* y ~) NThrombotic microangiopathy (TMA):血栓性微血管病" D8 M/ ~& u$ ]" h1 q- o# Z# U
TNF:tumor necrosis factor,肿瘤坏死因子2 q/ I/ I* i9 I2 s+ ~; s, U" |: W
TNI:total nodal irradiation,全淋巴结照射3 l* |1 |7 i ~/ d- l1 s% I
TOPO II:topoisomerase II,拓扑易构酶II
! n$ Y! l I; a0 r3 c+ c$ K" l3 J+ iToxin:毒素 ; E. a7 U9 z+ R( G1 S' E( s
Tpdt:potential doubling time,倍增时间' l% W' M+ g5 k/ K
T-PLL:T-prolymphocytic leukemia,T幼淋细胞白血病( E& I) ~3 [' E v
TPN:total parenteral nutrition,全肠道外营养,静脉高营养4 j9 }" J% @/ G: A
TPO:thrombopoietin,促血小板生成素
8 m6 a8 z& y3 y' L/ b7 u' yTPS:treatment planning system,治疗计划系统
* X [# o+ j, _# p9 p! zTranslocation:易位
( K0 {+ l/ L- u5 _) [5 YTrauma:创伤
& i& a2 J$ _2 y4 l- o3 V1 ^TRM:transplantation related mortality,移植相关死亡率9 G% K( s9 i+ ~ |1 V/ j; }
TSC:timed-sequential chemotherapy,时相序贯化疗
) K" w$ [% N }8 d; S4 TTSPA:triophosphoramide,噻替派. B& v0 k7 W, N$ u( o3 {9 W I5 \1 S
TTP:thrombotic thrombocytopenic purpura,血栓性血小板减少性紫癜
3 @7 @* m: A2 [2 L" }; c# O- z3 PTumor:肿瘤
) S, o+ `; y5 P: p3 W7 CTumor burden:肿瘤负荷
- ~3 B0 P3 k. D( |9 M& x; BUCB:umbilical cord blood,脐带血. U* x( x6 _) y. |7 K
Ultrasound:超声
7 i: i* @7 @2 _8 W; x7 Y' o6 ^Umbilical cord:脐带
$ M; X! R2 l/ r: d/ z9 W, MVAHS:viral associated hemophagocytic syndrome,病毒相关嗜血细胞综合征3 z) K. Q5 o0 U4 s5 |) X
VGPR:very good partial remission,非常良好的部分缓解' p+ Q" m4 ]: {1 l$ ?1 O
Viability:活性# X0 P0 a7 \4 P2 h
Virus:病毒
4 e* l$ z! U( M, }VOD:veno-occlusive disease,静脉阻塞性疾病 8 a4 `+ j T4 w3 L
v-onc: virus oncogene,病毒癌基因
- p* d+ w& u+ @3 c- lVPF: vascular permeability factor,血管渗透因子
4 m6 d2 b# a4 [VZV:varicella zoster virus,水痘带状疱疹病毒7 \% H( \! N+ K B! M
WBC:white blood cell,白细胞
4 o" O. E# Y( A% S1 T; sWhole blood:全血
/ R2 r2 Y; E$ V4 v9 aWT:Wilms tumor,肾母细胞瘤4 p7 S& E" l( `8 [4 H! g
Xerostomia:口腔干燥症
2 S/ X0 e) x" f4 u" DYield:产量 |
|